ACS Annual Statistics Report: Milestone 70% 5-Year Survival Rate for all Cancers Combined; Largest Gains for Advanced and Fatal Cancers
Jeffrey Bluestone: Kick-Ass Science, Collaborate Like Hell, Make a Difference
Call for Papers: Special Series on Cancer in Central Asia in 2026
Morocco to Launch Secure National Protocol App to Standardize Care Nationwide
France Expands Reimbursed Compassionate Access for Botensilimab/Balstilimab to Ovarian Cancer and Soft-Tissue Sarcomas
Elekta Foundation is Launching a FAST Pilot Screening Project in Bangladesh
The 100 Most Influential CEOs in Oncology in 2025 (Full List)
Michael Burns Appointed Senior Medical Director of Oncology Late Development at Pfizer
